Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
- PMID: 14724672
- DOI: 10.1038/sj.gt.3302213
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
Abstract
Plasmid vectors have been widely used for DNA vaccines and gene therapy. Following intramuscular injection, the plasmid that persists is extrachromosomal and integration into host DNA, if it occurs at all, is negligible. However, new technologies for improving DNA delivery could increase the frequency of integration. In the present study, we tested the effect of electroporation on plasmid uptake and potential integration following intramuscular injection in mice, using a plasmid containing the mouse erythropoietin gene. Electroporation increased plasmid tissue levels by approximately six- to 34-fold. Using a quantitative gel-purification assay for integration, electroporation was found to markedly increase the level of plasmid associated with high-molecular-weight genomic DNA. To confirm integration and identify the insertion sites, we developed a new assay - referred to as repeat-anchored integration capture (RAIC) PCR - that is capable of detecting rare integration events in a complex mixture in vivo. Using this assay, we identified four independent integration events. Sequencing of the insertion sites suggested a random integration process, but with short segments of homology between the vector breakpoint and the insertion site in three of the four cases. This is the first definitive demonstration of integration of plasmid DNA into genomic DNA following injection in vivo.
Similar articles
-
Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation.Gene Ther. 2002 Oct;9(20):1351-8. doi: 10.1038/sj.gt.3301806. Gene Ther. 2002. PMID: 12365000
-
Plasmid DNA vaccines: assay for integration into host genomic DNA.Dev Biol (Basel). 2000;104:33-43. Dev Biol (Basel). 2000. PMID: 11713822
-
Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer.J Gene Med. 1999 Jul-Aug;1(4):245-50. doi: 10.1002/(SICI)1521-2254(199907/08)1:4<245::AID-JGM49>3.0.CO;2-G. J Gene Med. 1999. PMID: 10738557
-
Progress and prospects: naked DNA gene transfer and therapy.Gene Ther. 2003 Mar;10(6):453-8. doi: 10.1038/sj.gt.3301983. Gene Ther. 2003. PMID: 12621449 Review.
-
Extrachromosomal plasmid vectors for gene therapy.Curr Opin Mol Ther. 2002 Aug;4(4):299-305. Curr Opin Mol Ther. 2002. PMID: 12222867 Review.
Cited by
-
Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation.Exp Mol Med. 2008 Dec 31;40(6):669-76. doi: 10.3858/emm.2008.40.6.669. Exp Mol Med. 2008. PMID: 19116452 Free PMC article.
-
Application of DNA Replicons in Gene Therapy and Vaccine Development.Pharmaceutics. 2023 Mar 15;15(3):947. doi: 10.3390/pharmaceutics15030947. Pharmaceutics. 2023. PMID: 36986808 Free PMC article. Review.
-
Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19).Arch Microbiol. 2023 Mar 30;205(4):150. doi: 10.1007/s00203-023-03480-5. Arch Microbiol. 2023. PMID: 36995507 Free PMC article. Review.
-
FDA guidance on prophylactic DNA vaccines: analysis and recommendations.Vaccine. 2010 Apr 1;28(16):2801-5. doi: 10.1016/j.vaccine.2009.11.025. Epub 2009 Nov 24. Vaccine. 2010. PMID: 19941989 Free PMC article. Review.
-
Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Vaccine. 2010 Jul 5;28(30):4827-36. doi: 10.1016/j.vaccine.2010.04.064. Epub 2010 May 6. Vaccine. 2010. PMID: 20451642 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical